Healthy Investments Ltd operates as an investment and financing company that generates income primarily through dividends and trading in equity shares and mutual funds.
The company lacks any identifiable competitive advantage, as evidenced by negative net margins and a return on capital employed that consistently fails to meet the cost of capital. Its performance is entirely dependent on the market fluctuations of its minority investment holdings rather than any proprietary business process or brand.
Capital is primarily deployed into a concentrated portfolio of public equities and liquid mutual funds. The track record is poor, characterized by volatile returns, a lack of dividend payments to shareholders, and a failure to generate meaningful organic growth from its capital base.
Five years later, the investment has halved because the regulatory hammer finally fell. The Reserve Bank of India shuttered the firm for operating without a mandatory registration, freezing the remaining assets. The concentrated equity portfolio, already suffering from poor selection and negative cash conversion, was liquidated at fire-sale prices during a market downturn. Management, which had already shown a lack of candor and high turnover, failed to pivot, and the family trust's control ensured that minority shareholders were the last to be considered during the dissolution.
RichFakir rates Healthy Investments Ltd's business quality as poor — 12/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
RichFakir's educational verdict on Healthy Investments Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Healthy Investments Ltd's fair value is about ₹1 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →